Advertisement
Evotec SE

Evotec SE (EVO) Stock Overview

Explore Evotec SE’s financial performance, market position, analyst ratings, and future outlook.

EVONASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$2.74
$0.03(1.11%)
U.S. Market opens in 54h 48m
Advertisement

Evotec SE (EVO)

Meyka AI Score

Z

Key Financials

Market Cap973.2M
P/E Ratio-4.39
EPS (TTM)$-0.71
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$2.76
3 Months$2.00
1 Year Target$3.02

EVO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Evotec SE (EVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.39 and a market capitalization of 973.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.11%
5-Day Change
4.58%
1-Month Change
-5.84%
3-Month Change
11.38%
6-Month Change
-11.90%
Year-to-Date (YTD) Change
-11.04%
1-Year Change
-35.07%
3-Year Change
-75.18%
5-Year Change
-87.99%
All-Time (Max) Change
166.02%

Contact Information

49 40 560 81 0
Essener Bogen 7, Hamburg, NaN, 22419

Company Facts

47,660 Employees
IPO DateFeb 5, 2004
CountryDE
Actively Trading

Frequently Asked Questions